Dr. Ujwal Gautam, MD

Dr. Gautam practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Gautam's NPI, 1669885646, was assigned on June 6, 2014. Dr. Gautam holds Maryland license D85860.

Dr. Gautam's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Gautam's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. Dr. Gautam is also affiliated with University of Maryland Baltimore Washington Medical Center. The medical group on file is University of Maryland Medical Center Gastroenterology and Hepatology.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gautam practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Gautam's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Gautam is licensed in Maryland.

CMS data shows 1,086 Medicare services from Dr. Gautam across 8 procedure codes in 2024, for 299 Medicare patients. Medicare paid $95,945 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 299 Medicare patients who saw Dr. Gautam in 2024. The largest group is under 65, with 171 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 37% are also on Medicaid. Their average risk score is 6.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gautam's median patient age at 61, with 32% women.

In 2024, Dr. Gautam wrote 1,878 Medicare Part D claims for 125 patients. 92% of them were for generic drugs. CMS names the drug for 1,762 of them, across 34 drugs with 11 or more claims each, at $132,096 in total drug cost. In 2023, CMS named 1,947 claims across 33 drugs.

Dr. Gautam accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 7 general payments to Dr. Gautam from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Calliditas Therapeutics US Inc. paid the most, $136.